| Mitotic and G2 Checkpoint Control: Regulation of 14-3-3 Protein Binding by Phosphorylation of Cdc25C on Serine-216 CY Peng, PR Graves, RS Thoma, Z Wu, AS Shaw, H Piwnica-Worms Science 277 (5331), 1501-1505, 1997 | 1872 | 1997 |
| All-oral daclatasvir plus asunaprevir for hepatitis C virus genotype 1b: a multinational, phase 3, multicohort study M Manns, S Pol, IM Jacobson, P Marcellin, SC Gordon, CY Peng, ... The Lancet 384 (9954), 1597-1605, 2014 | 458 | 2014 |
| Elbasvir–grazoprevir to treat hepatitis C virus infection in persons receiving opioid agonist therapy: a randomized trial GJ Dore, F Altice, AH Litwin, O Dalgard, EJ Gane, O Shibolet, ... Annals of internal medicine 165 (9), 625-634, 2016 | 436 | 2016 |
| Cyclin A/CDK2 binds directly to E2F-1 and inhibits the DNA-binding activity of E2F-1/DP-1 by phosphorylation M Xu, KA Sheppard, CY Peng, AS Yee, H Piwnica-Worms Molecular and cellular biology 14 (12), 8420-8431, 1994 | 427 | 1994 |
| C-TAK1 protein kinase phosphorylates human Cdc25C on serine 216 and promotes 14-3-3 protein binding CY Peng, PR Graves, S Ogg, RS Thoma, MJ Byrnes, Z Wu, ... Cell Growth and Differentiation-Publication American Association for Cancer …, 1998 | 325 | 1998 |
| Hepatitis B virus-related decompensated liver cirrhosis: benefits of antiviral therapy CY Peng, RN Chien, YF Liaw Journal of hepatology 57 (2), 442-450, 2012 | 311 | 2012 |
| Activation of nuclear factor κB in hepatitis C virus infection: implications for pathogenesis and hepatocarcinogenesis DI Tai, SL Tsai, YM Chen, YL Chuang, CY Peng, IS Sheen, CT Yeh, ... Hepatology 31 (3), 656-664, 2000 | 290 | 2000 |
| Efficacy and safety of entecavir versus adefovir in chronic hepatitis B patients with hepatic decompensation: a randomized, open‐label study YF Liaw, M Raptopoulou‐Gigi, H Cheinquer, SK Sarin, T Tanwandee, ... Hepatology 54 (1), 91-100, 2011 | 276 | 2011 |
| Omega-3 fatty acids in the prevention of interferon-alpha-induced depression: results from a randomized, controlled trial KP Su, HC Lai, HT Yang, WP Su, CY Peng, JPC Chang, HC Chang, ... Biological psychiatry 76 (7), 559-566, 2014 | 245 | 2014 |
| Four‐year entecavir therapy reduces hepatocellular carcinoma, cirrhotic events and mortality in chronic hepatitis B patients TH Su, TH Hu, CY Chen, YH Huang, WL Chuang, CC Lin, CC Wang, ... Liver International 36 (12), 1755-1764, 2016 | 231 | 2016 |
| Early hepatitis B virus DNA reduction in hepatitis B e antigen–positive patients with chronic hepatitis B: A randomized international study of entecavir versus adefovir N Leung, CY Peng, HW Hann, J Sollano, J Lao‐Tan, CW Hsu, L Lesmana, ... Hepatology 49 (1), 72-79, 2009 | 230 | 2009 |
| Effectiveness of elbasvir and grazoprevir combination, with or without ribavirin, for treatment-experienced patients with chronic hepatitis C infection P Kwo, EJ Gane, CY Peng, B Pearlman, JM Vierling, L Serfaty, M Buti, ... Gastroenterology 152 (1), 164-175. e4, 2017 | 222 | 2017 |
| Phospholipase A2 and cyclooxygenase 2 genes influence the risk of interferon-α–induced depression by regulating polyunsaturated fatty acids levels KP Su, SY Huang, CY Peng, HC Lai, CL Huang, YC Chen, KJ Aitchison, ... Biological psychiatry 67 (6), 550-557, 2010 | 201 | 2010 |
| Heparanase inhibitor PI-88 as adjuvant therapy for hepatocellular carcinoma after curative resection: a randomized phase II trial for safety and optimal dosage CJ Liu, PH Lee, DY Lin, CC Wu, LB Jeng, PW Lin, KT Mok, WC Lee, ... Journal of hepatology 50 (5), 958-968, 2009 | 171 | 2009 |
| Cell cycle regulation of the p34cdc2 inhibitory kinases. S Atherton-Fessler, F Liu, B Gabrielli, MS Lee, CY Peng, ... Molecular biology of the cell 5 (9), 989-1001, 1994 | 163 | 1994 |
| Phase III HEAT study adding lyso-thermosensitive liposomal doxorubicin to radiofrequency ablation in patients with unresectable hepatocellular carcinoma lesions WY Tak, SM Lin, Y Wang, J Zheng, A Vecchione, SY Park, MH Chen, ... Clinical Cancer Research 24 (1), 73-83, 2018 | 159 | 2018 |
| Gallstone ileus: report of two cases and review of the literature JW Chou, CH Hsu, KF Liao, HC Lai, KS Cheng, CY Peng, MD Yang, ... World journal of gastroenterology: WJG 13 (8), 1295, 2007 | 131 | 2007 |
| Peginterferon lambda for the treatment of HBeAg-positive chronic hepatitis B: A randomized phase 2b study (LIRA-B) HLY Chan, SH Ahn, TT Chang, CY Peng, D Wong, CS Coffin, SG Lim, ... Journal of hepatology 64 (5), 1011-1019, 2016 | 128 | 2016 |
| Efficacy of ledipasvir and sofosbuvir treatment of HCV infection in patients coinfected with HBV CJ Liu, WL Chuang, IS Sheen, HY Wang, CY Chen, KC Tseng, TT Chang, ... Gastroenterology 154 (4), 989-997, 2018 | 125 | 2018 |
| Safety and efficacy of elbasvir/grazoprevir in patients with hepatitis C virus infection and compensated cirrhosis: an integrated analysis IM Jacobson, E Lawitz, PY Kwo, C Hézode, CY Peng, AYM Howe, ... Gastroenterology 152 (6), 1372-1382. e2, 2017 | 120 | 2017 |
